Apollo Hospitals Enterprise Ltd. (AHEL) on Friday announced its intention to acquire 31% stake held by International Finance Corporation in Apollo Health and Lifestyle Limited (AHLL), a subsidiary of AHEL, for a consideration of ₹ 1,254 crore.
Following the transaction, AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool. The acquisition of the shares are expected to be completed by end of November 2025, subject to regulatory approvals and completion of customary closing formalities.
Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise Ltd., said, “This acquisition is a decisive step that will allow for sharper capital allocation and a greater focus on select high-potential segments. With disciplined growth, improved profitability, and enhanced return on capital employed (ROCE), we see AHLL becoming a value-accretive driver in Apollo’s integrated healthcare portfolio.”
“By bringing AHLL fully into Apollo’s fold, we are sharpening the business focus across its four verticals – primary care and diagnostics, birthing and women’s health, ambulatory care, and dialysis and dental. This sharper focus will enable AHLL to scale more effectively, innovate faster, and serve patients with care models that are more personalised, accessible, and future-ready,” said Sangita Reddy, Joint Managing Director, Apollo Hospitals Enterprise Ltd.
Apollo Hospitals also announced plans to set up a 100-bed comprehensive oncology centre at Gurugram, The centre will be set up as part of the Phase 2 expansion of its upcoming 500-bed hospital in Gurugram. The Phase 1 development at Gurugram is on track to be commissioned by end Q4 FY25/Ql FY26, while the Proton and Integrated Cancer Centre will follow with completion targeted over the next four years.
Published – September 12, 2025 10:18 pm IST
